drugset / Trial / NCT01845792
Study of Abiraterone Acetate and Prednisone in Combination With Cabazitaxel in Patients With Prostate Cancer
RandomizedSingle-groupOpen-labelTreatment
Summary
Patients are being asked to take place in this research study because they have advanced prostate cancer that has gotten worse after other treatments. If they join this study they will receive a new combination of drugs that are used to treat prostate cancer.
Timeline
- Start
- 2013-07
- Primary completion
- 2017-02
- Completion
- 2017-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Abiraterone acetate | Small molecule | — | Oral |
| Subject | Cabazitaxel | Other / unclassified | — | Intravenous |
| Background | Prednisone | Other / unclassified | — | Oral |